Alphabet soup, treatment setbacks and Black Friday(s)

<p>As the market reverses lower, some investors could be misreading the signs when picking a letter to describe the economic recovery. We’ll explain.</p><p>Plus, Eli Lilly is pausing its Covid antibody drug trial, now the second virus treatment setback this week. Should investors rethink their strategy in the healthcare space? We’ll debate. </p><p>And, Walmart is throwing out its Black Friday playbook, and breaking it up into three separate sales events. Could this be a winning strategy? We explore in Rapid Fire. </p>